FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Women who miss their first mammogram face higher risk of breast cancer death, study finds

2.

'Sleep ALL night' program helps children with leukemia sleep better during treatment

3.

Ineffective medication can remove the "worst fear" of schizophrenia.

4.

Q&A: Breast cancer facts that could save lives

5.

FDA Investigating Blood Cancer Risk With Gene Therapy Skysona


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot